Izvorni znanstveni članak
THROMBOPROPHYLAXIS IN PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ADMITTED IN UNIVERSITY HOSPITAL SPLIT, CROATIA, DUE TO THE ISCHAEMIC STROKE IN RELATION TO THROMBOEMBOLIC AND BLEEDING RISK
IVANA CVITKOVIĆ
orcid.org/0000-0002-4199-3905
; Privatna kardiološka ordinacija "dr Rakić", Split, Hrvatska
IVONA BOŽIĆ
; Klinički bolnički centar Split, Klinika za unutarnje bolesti, Split, Hrvatska
VEDRAN CAREVIĆ
; Klinički bolnički centar Split, Zavod za bolesti srca i krvnih žila, Split, Hrvatska
KREŠIMIR ČALJKUŠIĆ
; Klinički bolnički centar Split, Klinika za neurologiju, Split, Hrvatska
ANTON MAROVIĆ
; Klinički bolnički centar Split, Klinika za neurologiju, Split, Hrvatska
IVO LUŠIĆ
; Klinički bolnički centar Split, Klinika za neurologiju, Split, Hrvatska
DAMIR FABIJANIĆ
; Klinički bolnički centar Split, Zavod za bolesti srca i krvnih žila, Split, Hrvatska
Sažetak
Aim of the study was to assess the concordance of the thromboprophylactic treatment in patients with nonvalvular atrial ibrillation (nAF) at the time of admission due to ischemic stroke with clinical guidelines of the European Society of Cardiology. Methods: In the cross-sectional study were included 327 patients [143 (44%) males] treated because of ischemic stroke associated with nAF. The index of the thromboembolic risk (TE) has been established by the CHA2DS2-VASc score, whereas the bleeding risk has been assessed by the HAS-BLED score. Results: Before the ischemic stroke, 98.2% of patients belonged to the group of high TE risk. Among these patients only 179 (55%) were received thromboprophylaxis: 67.5% patients acetylsalicylic acid, 30.5% warfarin, and 4% clopidogrel. Previous ischemic stroke was independently correlated with warfarin administration (OR 2.5; 95% CI 1.4-4.5; p=0.003), while poorly controlled arterial hypertension was independently correlated with warfarin non-administration (OR 0.47; 95% CI 0.25-0.88; p=0.019). The 83.7% of 55 patients, who experienced ischemic stroke during anticoagulant treatment, had an INR values lower than therapeutic. Conclusion: Thromboprophylaxis among the patients with nAF admitted because of ischemic stroke did not correlate with their TE risk and contemporary guidelines of the European Society of Cardiology.
Ključne riječi
stroke; atrial ibrillation; anticoagulant therapy; thromboprophylaxis
Hrčak ID:
147980
URI
Datum izdavanja:
4.11.2015.
Posjeta: 2.040 *